galactosyl-(1-3)galactose has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, XF; Fei, J; Guo, LH; Xia, GH; Xing, L | 1 |
| Ikeda, Y; Iwamori, M; Kashiwagi, M; Nagai, Y; Toda, G | 1 |
2 other study(ies) available for galactosyl-(1-3)galactose and Cancer of Liver
| Article | Year |
|---|---|
Adenovirus-mediated expression of antisense RNA transcripts complementary to pig alpha(1,3) galactosyltransferase mRNA inhibits expression of Gal alpha(1,3) Gal epitope.
Topics: 3T3 Cells; Adenoviruses, Human; Animals; Carcinoma, Hepatocellular; Cell Line; Disaccharides; Down-Regulation; Embryo, Mammalian; Fucosyltransferases; Galactoside 2-alpha-L-fucosyltransferase; Galactosyltransferases; Gene Expression; Humans; Kidney; Liver Neoplasms; Mice; RNA, Antisense; RNA, Messenger; Transfection; Tumor Cells, Cultured | 2000 |
Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.
Topics: Animals; Antibodies, Neoplasm; Antigens, Neoplasm; Carcinoma, Hepatocellular; Chronic Disease; Disaccharides; Embolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Glycosphingolipids; Humans; Immunoglobulin G; Liver Diseases; Liver Neoplasms; Rabbits | 1989 |